Tag: stock market analysis
What Semiconductors ETF (SMH) Is Telling Broader Stock Market?
The Semiconductor Sector ETF (NASDAQ:SMH) is a huge piece of the what-happens-next puzzle for tech stocks and perhaps the broader stock market.
Those who know me...
Alphabet Sets Positive Tone Ahead of Tech Earnings
With 12% of S&P 500 companies reporting for the Q1 reporting season, EPS growth currently stands at 10.1%
Eight companies reporting this week have advanced...
Key Stock Market ETFs, Bitcoin Creating A Story
This past week I wrote a lot about the relationship between silver, gold, bonds, the dollar and S&P 500.
I also spoke in the media...
Is Viking Therapeutics Stock (VKTX) Nearing A Bottom?
With earnings scheduled for the 23rd, Viking Therapeutic's (NASDAQ: VKTX) first-quarter investor call is expected to center around key pipeline updates.
The spotlight will be...
2025 Shareholder Meeting Season Calendar and Highlights
As earnings reports roll in, investors shouldn’t overlook Annual General Meetings
These gatherings provide color on firm-specific and macro trends
Strategic plans are outlined, activists can...
$XAR Aerospace & Defense Sector Poised For Breakout
Global tensions in Eastern Europe and the Middle East have given the world reason for concern over a larger conflict.
And these concerns appear to...
Are Bitcoin and Key Stock Market ETFs Saying Different Things?
Friday the markets are closed, and I am taking a brief hiatus beginning Thursday April 17, returning Monday April 21.
Over the past week, I...
Worried About the Death Cross in Magnificent 7 ETF (MAGS)?
Many analysts are still out there touting the great opportunity in the MAG 7 (Magnificent 7) stocks. Today we examine this using the Magnificent...
Bank Stocks Outperform Q1 Earnings, but Cautious for 2025
Bank stocks blew Q1 earnings expectations out of the water, benefitting from high trading volumes, but CEO commentary remains cautious for 2025
Despite the tone...
After Tariff Flush, a Fresh Look at AbbVie Pharma (ABBV)
In my 2025 Outlook, I picked AbbVie Pharmaceuticals (NYSE: ABBV) as one to watch this year.
Here is what I wrote:
AbbVie (ABBV) AbbVie primarily works...